[{"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "3000.00", "Date_of_Payment": "02/08/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "158723048", "Nature_of_Payment_or_Transfer_of_Value": "Consulting Fee", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "3000.00", "Date_of_Payment": "10/30/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "295476102", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "3000.00", "Date_of_Payment": "12/04/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "295476120", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "3000.00", "Date_of_Payment": "12/23/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "295476138", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "1750.00", "Date_of_Payment": "11/04/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "295476106", "Nature_of_Payment_or_Transfer_of_Value": "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "1061.20", "Date_of_Payment": "11/18/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "295476114", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "1000.00", "Date_of_Payment": "12/12/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "158750198", "Nature_of_Payment_or_Transfer_of_Value": "Honoraria", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "APRISO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "595.07", "Date_of_Payment": "09/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29418861", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Solesta", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "568.84", "Date_of_Payment": "02/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158812038", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boston Scientific Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005674", "Total_Amount_of_Payment_USDollars": "512.86", "Date_of_Payment": "04/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "246094792", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "390.63", "Date_of_Payment": "11/18/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "295476118", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "250.00", "Date_of_Payment": "09/20/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "29420823", "Nature_of_Payment_or_Transfer_of_Value": "Honoraria", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Apriso", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "218.42", "Date_of_Payment": "09/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29418863", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Solesta", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "131.49", "Date_of_Payment": "11/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158775542", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "131.49", "Date_of_Payment": "01/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230510", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "107.42", "Date_of_Payment": "12/23/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "295476130", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "106.99", "Date_of_Payment": "12/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158896408", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "APRISO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "106.99", "Date_of_Payment": "01/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230506", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "APRISO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "106.84", "Date_of_Payment": "09/04/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29419539", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Solesta", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "104.77", "Date_of_Payment": "10/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158774458", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000232", "Total_Amount_of_Payment_USDollars": "104.46", "Date_of_Payment": "08/27/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23724664", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Invega Sustenna", "Name_of_Associated_Covered_Drug_or_Biological2": "Risperdal Consta", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "102.35", "Date_of_Payment": "02/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158723053", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "101.37", "Date_of_Payment": "01/09/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "295230518", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "92.36", "Date_of_Payment": "11/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194000918", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "ENTYVIO", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "92.30", "Date_of_Payment": "12/19/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29418202", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "84.57", "Date_of_Payment": "10/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295476098", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "82.30", "Date_of_Payment": "09/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29418859", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Solesta", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "75.23", "Date_of_Payment": "07/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158787726", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "68.61", "Date_of_Payment": "02/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158719710", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "64.56", "Date_of_Payment": "10/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295476096", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "64.40", "Date_of_Payment": "09/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29418856", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Solesta", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "63.44", "Date_of_Payment": "09/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29418854", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Solesta", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "57.76", "Date_of_Payment": "05/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339859872", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "55.61", "Date_of_Payment": "12/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295476124", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "40.56", "Date_of_Payment": "02/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158710495", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "38.50", "Date_of_Payment": "09/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29418864", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Solesta", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "37.53", "Date_of_Payment": "02/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158719714", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "36.00", "Date_of_Payment": "02/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158715149", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "28.57", "Date_of_Payment": "12/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295476128", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "27.54", "Date_of_Payment": "10/23/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "102069326", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "24.46", "Date_of_Payment": "11/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295476110", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "22.69", "Date_of_Payment": "09/11/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29411630", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "22.04", "Date_of_Payment": "05/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158838854", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "UCERIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "21.72", "Date_of_Payment": "12/17/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29418206", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xifaxan 550 mg", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "21.18", "Date_of_Payment": "05/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149663038", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Santarus, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010767", "Total_Amount_of_Payment_USDollars": "20.75", "Date_of_Payment": "10/24/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "26871372", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Uceris", "Name_of_Associated_Covered_Drug_or_Biological2": "Zegerid", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "20.23", "Date_of_Payment": "01/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050745", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "19.70", "Date_of_Payment": "01/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "299162716", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "19.58", "Date_of_Payment": "09/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252774924", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "19.50", "Date_of_Payment": "07/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149669600", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "19.49", "Date_of_Payment": "05/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156186382", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "19.40", "Date_of_Payment": "01/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230522", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "19.27", "Date_of_Payment": "03/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230534", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "19.04", "Date_of_Payment": "07/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "187478580", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "DELZICOL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "18.87", "Date_of_Payment": "04/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317235130", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "18.74", "Date_of_Payment": "04/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050748", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "18.69", "Date_of_Payment": "09/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "169208842", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "18.64", "Date_of_Payment": "02/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189183372", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "18.36", "Date_of_Payment": "09/01/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104616414", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ironwood Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000245", "Total_Amount_of_Payment_USDollars": "18.31", "Date_of_Payment": "07/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "324961610", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS 145 mcg", "Name_of_Associated_Covered_Drug_or_Biological2": "LINZESS 290 mcg", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "18.26", "Date_of_Payment": "08/27/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "102069316", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "18.19", "Date_of_Payment": "08/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158804056", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "17.98", "Date_of_Payment": "09/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339655470", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "17.93", "Date_of_Payment": "09/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104616412", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "17.89", "Date_of_Payment": "10/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189550526", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Moderiba", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "17.88", "Date_of_Payment": "02/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260215248", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "17.84", "Date_of_Payment": "04/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317240718", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "17.84", "Date_of_Payment": "03/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337042970", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "17.78", "Date_of_Payment": "03/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156186378", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ironwood Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000245", "Total_Amount_of_Payment_USDollars": "17.77", "Date_of_Payment": "12/04/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "100713366", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS 145 mcg", "Name_of_Associated_Covered_Drug_or_Biological2": "LINZESS 290 mcg", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "17.76", "Date_of_Payment": "11/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "170086672", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "17.70", "Date_of_Payment": "03/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "299162728", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "17.61", "Date_of_Payment": "05/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050754", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "17.58", "Date_of_Payment": "11/28/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104616408", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "17.33", "Date_of_Payment": "06/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050759", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "17.30", "Date_of_Payment": "02/12/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158574642", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "RELISTOR", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "17.09", "Date_of_Payment": "07/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189423652", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "17.03", "Date_of_Payment": "09/24/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "25326526", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Dexilant", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "16.92", "Date_of_Payment": "09/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158556838", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "16.92", "Date_of_Payment": "03/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317260012", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "16.80", "Date_of_Payment": "05/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "170086670", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "16.77", "Date_of_Payment": "04/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050750", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "16.76", "Date_of_Payment": "07/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300661768", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "16.75", "Date_of_Payment": "10/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156186376", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "16.70", "Date_of_Payment": "01/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260209460", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "16.65", "Date_of_Payment": "01/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158699760", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "16.64", "Date_of_Payment": "10/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317235270", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Viekira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "16.61", "Date_of_Payment": "10/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317254762", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "16.58", "Date_of_Payment": "02/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156186390", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi Aria", "Name_of_Associated_Covered_Drug_or_Biological2": "Remicade", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "16.47", "Date_of_Payment": "06/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300266050", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boston Scientific Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005674", "Total_Amount_of_Payment_USDollars": "16.46", "Date_of_Payment": "05/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "246094794", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "16.42", "Date_of_Payment": "07/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050768", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "16.37", "Date_of_Payment": "06/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252771956", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "16.35", "Date_of_Payment": "03/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149655262", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "16.24", "Date_of_Payment": "01/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317168388", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "16.22", "Date_of_Payment": "06/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337212216", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Dexilant", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "16.18", "Date_of_Payment": "09/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317184236", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "16.17", "Date_of_Payment": "08/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156186386", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "16.06", "Date_of_Payment": "02/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050788", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "Remicade", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "16.02", "Date_of_Payment": "08/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "187478582", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "DELZICOL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "16.01", "Date_of_Payment": "09/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158705128", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "APRISO", "Name_of_Associated_Covered_Drug_or_Biological2": "XIFAXAN 550 MG TABLETS", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "15.96", "Date_of_Payment": "07/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158781360", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "15.81", "Date_of_Payment": "11/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136396428", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "15.68", "Date_of_Payment": "03/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230538", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN - 550MG", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.63", "Date_of_Payment": "12/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317010716", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ironwood Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000245", "Total_Amount_of_Payment_USDollars": "15.60", "Date_of_Payment": "08/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "191591670", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS 145 mcg", "Name_of_Associated_Covered_Drug_or_Biological2": "LINZESS 290 mcg", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.56", "Date_of_Payment": "09/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189519112", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "15.52", "Date_of_Payment": "02/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252767406", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "15.46", "Date_of_Payment": "11/19/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158547796", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "APRISO", "Name_of_Associated_Covered_Drug_or_Biological2": "XIFAXAN 550 MG TABLETS", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "15.41", "Date_of_Payment": "04/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156186380", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "15.39", "Date_of_Payment": "02/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156186372", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OLYSIO", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "15.28", "Date_of_Payment": "10/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050734", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "REMICADE", "Name_of_Associated_Covered_Drug_or_Biological2": "SIMPONI", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "15.21", "Date_of_Payment": "10/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252776090", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "15.19", "Date_of_Payment": "09/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149674440", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.14", "Date_of_Payment": "11/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104616410", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.13", "Date_of_Payment": "10/08/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104616406", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "15.10", "Date_of_Payment": "07/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158581900", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.09", "Date_of_Payment": "06/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189388148", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.09", "Date_of_Payment": "08/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189463934", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "15.01", "Date_of_Payment": "10/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "169208848", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "14.87", "Date_of_Payment": "09/04/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "102076720", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "14.85", "Date_of_Payment": "04/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230558", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN - 550MG", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "14.82", "Date_of_Payment": "08/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158645406", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "14.78", "Date_of_Payment": "02/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "299162722", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "14.75", "Date_of_Payment": "08/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189442186", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "14.69", "Date_of_Payment": "07/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "169208833", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "14.63", "Date_of_Payment": "09/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337334448", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "14.62", "Date_of_Payment": "02/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339474682", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "DELZICOL", "Name_of_Associated_Covered_Drug_or_Biological2": "ASACOL HD", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "14.59", "Date_of_Payment": "12/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "169208856", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "14.59", "Date_of_Payment": "08/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317393904", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "14.49", "Date_of_Payment": "11/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050720", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "REMICADE", "Name_of_Associated_Covered_Drug_or_Biological2": "SIMPONI", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "14.48", "Date_of_Payment": "10/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158555336", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "14.38", "Date_of_Payment": "09/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194000914", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "14.38", "Date_of_Payment": "08/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260195866", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "14.34", "Date_of_Payment": "08/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149671374", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Pharma US Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000137", "Total_Amount_of_Payment_USDollars": "14.33", "Date_of_Payment": "12/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168894328", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Vesicare", "Name_of_Associated_Covered_Drug_or_Biological2": "Myrbetriq", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "14.27", "Date_of_Payment": "12/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149683292", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "14.21", "Date_of_Payment": "05/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189335796", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "14.16", "Date_of_Payment": "12/23/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23823118", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "Olysio", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "14.16", "Date_of_Payment": "03/27/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189239766", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "14.10", "Date_of_Payment": "09/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158874860", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "14.01", "Date_of_Payment": "10/13/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149677976", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "14.00", "Date_of_Payment": "01/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189107340", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "14.00", "Date_of_Payment": "04/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300266032", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "13.99", "Date_of_Payment": "04/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "170086668", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "13.99", "Date_of_Payment": "04/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230546", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN - 550MG", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "13.97", "Date_of_Payment": "10/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260193346", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Gilead Sciences Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000108", "Total_Amount_of_Payment_USDollars": "13.87", "Date_of_Payment": "10/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168239724", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "724108-1821202-8032620 - 1633695 - 20430892-1633695-Gilead Sciences-VRL"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "13.79", "Date_of_Payment": "09/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189523074", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "13.76", "Date_of_Payment": "07/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317234462", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ironwood Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000245", "Total_Amount_of_Payment_USDollars": "13.73", "Date_of_Payment": "04/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "324941354", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS 145 mcg", "Name_of_Associated_Covered_Drug_or_Biological2": "LINZESS 290 mcg", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "13.71", "Date_of_Payment": "09/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156186388", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "13.71", "Date_of_Payment": "08/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252773996", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "13.69", "Date_of_Payment": "06/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339420030", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "13.66", "Date_of_Payment": "05/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300266040", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "13.65", "Date_of_Payment": "01/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189137700", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "13.65", "Date_of_Payment": "04/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260191422", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "13.51", "Date_of_Payment": "07/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337267762", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cook Incorporated", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010458", "Total_Amount_of_Payment_USDollars": "13.48", "Date_of_Payment": "07/03/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "211362050", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Physicians are provided modest meals during the course of doing business with Cook Medical. The physician could be attending or presenting at an educational presentation or a product training session. We also invite physicians to dinners to give us feedback on our products or to advise us on trends in medical procedures and treatments. The total cost of a group's food and beverages at a meal are averaged across attendees."}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "13.48", "Date_of_Payment": "11/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317279790", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "13.46", "Date_of_Payment": "12/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158888860", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "13.46", "Date_of_Payment": "01/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230514", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "13.44", "Date_of_Payment": "02/24/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "308902764", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "13.33", "Date_of_Payment": "09/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136396424", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "13.33", "Date_of_Payment": "06/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339398494", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "13.31", "Date_of_Payment": "04/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194000902", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "13.18", "Date_of_Payment": "12/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050738", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "REMICADE", "Name_of_Associated_Covered_Drug_or_Biological2": "SIMPONI", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "13.17", "Date_of_Payment": "09/24/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050783", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "13.12", "Date_of_Payment": "07/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "146773302", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "13.04", "Date_of_Payment": "09/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "102069320", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "12.90", "Date_of_Payment": "08/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "316964194", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.87", "Date_of_Payment": "01/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050710", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OLYSIO", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "12.85", "Date_of_Payment": "06/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189380176", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "12.84", "Date_of_Payment": "05/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189345790", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.78", "Date_of_Payment": "07/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050764", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "12.74", "Date_of_Payment": "01/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252766008", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.64", "Date_of_Payment": "11/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050726", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "REMICADE", "Name_of_Associated_Covered_Drug_or_Biological2": "SIMPONI", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ironwood Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000245", "Total_Amount_of_Payment_USDollars": "12.60", "Date_of_Payment": "12/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "191591674", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS 145 mcg", "Name_of_Associated_Covered_Drug_or_Biological2": "LINZESS 290 mcg", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "12.59", "Date_of_Payment": "12/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "301064106", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "12.58", "Date_of_Payment": "10/27/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189566766", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "12.53", "Date_of_Payment": "07/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317285984", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Endo Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000285", "Total_Amount_of_Payment_USDollars": "12.45", "Date_of_Payment": "07/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "338807924", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIAFLEX", "Name_of_Associated_Covered_Drug_or_Biological2": "AVEED", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "12.42", "Date_of_Payment": "04/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252769454", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "12.41", "Date_of_Payment": "01/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "309347010", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "12.34", "Date_of_Payment": "01/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339341076", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.31", "Date_of_Payment": "07/31/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156186384", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "12.29", "Date_of_Payment": "05/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158592716", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "APRISO", "Name_of_Associated_Covered_Drug_or_Biological2": "XIFAXAN 550 MG TABLETS", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.22", "Date_of_Payment": "12/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156186374", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Olysio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "12.18", "Date_of_Payment": "01/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "336825798", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "12.16", "Date_of_Payment": "10/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136396426", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "12.15", "Date_of_Payment": "08/13/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "170086674", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "12.15", "Date_of_Payment": "03/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252768744", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "12.00", "Date_of_Payment": "12/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "301064114", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Valeant Pharmaceuticals North America LLC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010935", "Total_Amount_of_Payment_USDollars": "12.00", "Date_of_Payment": "12/23/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "295476134", "Nature_of_Payment_or_Transfer_of_Value": "Travel and Lodging", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "11.87", "Date_of_Payment": "01/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "146773290", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "11.75", "Date_of_Payment": "12/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260180786", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "11.72", "Date_of_Payment": "07/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136396422", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "11.59", "Date_of_Payment": "02/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230530", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "11.54", "Date_of_Payment": "11/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339260396", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "VIBERZI", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "11.46", "Date_of_Payment": "05/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260178344", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "11.45", "Date_of_Payment": "01/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230528", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN - 550MG", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "11.40", "Date_of_Payment": "08/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050774", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "11.40", "Date_of_Payment": "10/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "301064100", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "11.33", "Date_of_Payment": "11/29/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29411829", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xifaxan 550 mg", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "11.33", "Date_of_Payment": "02/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "309118441", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "11.30", "Date_of_Payment": "07/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339240922", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "DELZICOL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "11.28", "Date_of_Payment": "05/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252770564", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "11.22", "Date_of_Payment": "11/20/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "219486960", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Lotronex", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "11.22", "Date_of_Payment": "04/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337087712", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "11.13", "Date_of_Payment": "04/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "326471746", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Covered-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "11.13", "Date_of_Payment": "04/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337094146", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "11.11", "Date_of_Payment": "12/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136396430", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ferring Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000309", "Total_Amount_of_Payment_USDollars": "11.05", "Date_of_Payment": "10/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "192238234", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PREPOPIK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "11.00", "Date_of_Payment": "10/23/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "219499914", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Lotronex", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "10.95", "Date_of_Payment": "07/02/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "219493274", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Lotronex", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "10.85", "Date_of_Payment": "08/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339205734", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "10.69", "Date_of_Payment": "08/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050778", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ferring Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000309", "Total_Amount_of_Payment_USDollars": "10.55", "Date_of_Payment": "11/26/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "102092700", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PREPOPIK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ferring Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000309", "Total_Amount_of_Payment_USDollars": "10.53", "Date_of_Payment": "12/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "102092702", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PREPOPIK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "10.50", "Date_of_Payment": "02/11/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "170899292", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "10.48", "Date_of_Payment": "12/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317063719", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "10.43", "Date_of_Payment": "09/08/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "219490368", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Lotronex", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "10.39", "Date_of_Payment": "08/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189472116", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "10.30", "Date_of_Payment": "11/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29797817", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Pegasys", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "10.19", "Date_of_Payment": "01/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189151126", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "10.19", "Date_of_Payment": "07/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260167596", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "10.15", "Date_of_Payment": "02/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050716", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OLYSIO", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "10.04", "Date_of_Payment": "05/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194000904", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "9.91", "Date_of_Payment": "10/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194000916", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "9.88", "Date_of_Payment": "10/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158889806", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "APRISO", "Name_of_Associated_Covered_Drug_or_Biological2": "XIFAXAN 550 MG TABLETS", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "9.87", "Date_of_Payment": "12/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337431796", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "9.74", "Date_of_Payment": "04/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "146773286", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "9.63", "Date_of_Payment": "07/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337244882", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Given Imaging, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000348", "Total_Amount_of_Payment_USDollars": "9.45", "Date_of_Payment": "09/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "325021320", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "9.26", "Date_of_Payment": "08/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194000908", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "9.14", "Date_of_Payment": "06/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194000906", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "8.97", "Date_of_Payment": "02/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339106650", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "8.93", "Date_of_Payment": "03/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158583918", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "RELISTOR", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Given Imaging, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000348", "Total_Amount_of_Payment_USDollars": "8.89", "Date_of_Payment": "09/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "325021314", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "8.83", "Date_of_Payment": "08/07/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "25326523", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "8.76", "Date_of_Payment": "03/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "146773282", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "8.54", "Date_of_Payment": "06/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "146773299", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "8.54", "Date_of_Payment": "02/23/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194000910", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Dexilant", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "8.08", "Date_of_Payment": "04/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149659318", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Boston Scientific Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005674", "Total_Amount_of_Payment_USDollars": "7.86", "Date_of_Payment": "05/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "246094796", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "7.81", "Date_of_Payment": "03/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050794", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "Remicade", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "7.78", "Date_of_Payment": "12/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270050740", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "7.67", "Date_of_Payment": "05/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "146773296", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PYLERA", "Name_of_Associated_Covered_Drug_or_Biological2": "CANASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "6.49", "Date_of_Payment": "09/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317128878", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Viekira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "5.36", "Date_of_Payment": "01/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149650754", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "5.01", "Date_of_Payment": "03/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302178086", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "4.76", "Date_of_Payment": "10/16/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "25326524", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "4.60", "Date_of_Payment": "01/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "146773278", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "4.40", "Date_of_Payment": "05/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302188872", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "4.39", "Date_of_Payment": "10/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302212690", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "3.60", "Date_of_Payment": "09/21/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "29420133", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Solesta", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "3.08", "Date_of_Payment": "02/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "338946992", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "DELZICOL", "Name_of_Associated_Covered_Drug_or_Biological2": "ASACOL HD", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "1.70", "Date_of_Payment": "10/15/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "25326525", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "0.84", "Date_of_Payment": "05/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189335794", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.83", "Date_of_Payment": "07/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302196470", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.71", "Date_of_Payment": "10/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158554448", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.62", "Date_of_Payment": "01/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302169712", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.61", "Date_of_Payment": "08/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158730587", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "UCERIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.61", "Date_of_Payment": "03/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230542", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN - 550MG", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.59", "Date_of_Payment": "06/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302194338", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.59", "Date_of_Payment": "04/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230550", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN - 550MG", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "0.58", "Date_of_Payment": "01/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189107342", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.56", "Date_of_Payment": "10/29/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29413195", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xifaxan 550 mg", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.56", "Date_of_Payment": "04/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295230555", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN - 550MG", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.52", "Date_of_Payment": "02/12/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158787766", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "UCERIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.52", "Date_of_Payment": "05/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158644466", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.48", "Date_of_Payment": "11/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158574368", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.47", "Date_of_Payment": "11/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302221422", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.45", "Date_of_Payment": "01/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158654762", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "0.44", "Date_of_Payment": "09/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337334468", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.41", "Date_of_Payment": "03/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158612524", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "UCERIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "0.41", "Date_of_Payment": "02/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194000912", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Dexilant", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.40", "Date_of_Payment": "09/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158705376", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "APRISO", "Name_of_Associated_Covered_Drug_or_Biological2": "XIFAXAN 550 MG TABLETS", "Contextual_Information": ""}, {"Physician_Profile_ID": "38765", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.21", "Date_of_Payment": "12/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302228124", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}]